Johnson & Johnson Exceeds Expectations in First Post-Spinoff Quarterly Report
October 17, 2023
In its initial quarterly report following the separation from its consumer health spinoff Kenvue in August, Johnson & Johnson (J&J) has outperformed Wall Street’s expectations,